nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—ABCB1—ovarian cancer	0.282	1	CbGaD
Levofloxacin—TOP2A—Epirubicin—ovarian cancer	0.159	0.366	CbGbCtD
Levofloxacin—TOP2A—Doxorubicin—ovarian cancer	0.0845	0.194	CbGbCtD
Levofloxacin—ABCB1—Topotecan—ovarian cancer	0.0424	0.0974	CbGbCtD
Levofloxacin—ABCB1—Vinorelbine—ovarian cancer	0.0299	0.0686	CbGbCtD
Levofloxacin—CYP3A4—Topotecan—ovarian cancer	0.0254	0.0584	CbGbCtD
Levofloxacin—ABCB1—Paclitaxel—ovarian cancer	0.021	0.0482	CbGbCtD
Levofloxacin—CYP3A4—Vinorelbine—ovarian cancer	0.0179	0.0411	CbGbCtD
Levofloxacin—ABCB1—Docetaxel—ovarian cancer	0.0152	0.0349	CbGbCtD
Levofloxacin—CYP3A4—Paclitaxel—ovarian cancer	0.0126	0.0289	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—ovarian cancer	0.0113	0.026	CbGbCtD
Levofloxacin—CYP3A4—Docetaxel—ovarian cancer	0.00909	0.0209	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—ovarian cancer	0.00677	0.0156	CbGbCtD
Levofloxacin—TOP2A—myometrium—ovarian cancer	0.00132	0.0811	CbGeAlD
Levofloxacin—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.00114	0.219	CbGdCrCtD
Levofloxacin—SLC22A4—myometrium—ovarian cancer	0.00105	0.0649	CbGeAlD
Levofloxacin—TOP2A—uterine cervix—ovarian cancer	0.00102	0.0631	CbGeAlD
Levofloxacin—TOP2A—decidua—ovarian cancer	0.000976	0.0601	CbGeAlD
Levofloxacin—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.000975	0.187	CbGdCrCtD
Levofloxacin—TOP2A—endometrium—ovarian cancer	0.000926	0.0571	CbGeAlD
Levofloxacin—TOP2A—uterus—ovarian cancer	0.000853	0.0526	CbGeAlD
Levofloxacin—SLC22A4—decidua—ovarian cancer	0.000781	0.0481	CbGeAlD
Levofloxacin—SLC22A4—endometrium—ovarian cancer	0.000741	0.0457	CbGeAlD
Levofloxacin—TOP2A—bone marrow—ovarian cancer	0.000724	0.0446	CbGeAlD
Levofloxacin—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.000724	0.139	CbGdCrCtD
Levofloxacin—TOP2A—female gonad—ovarian cancer	0.000698	0.043	CbGeAlD
Levofloxacin—TOP2A—vagina—ovarian cancer	0.000694	0.0428	CbGeAlD
Levofloxacin—TOP2A—testis—ovarian cancer	0.000619	0.0382	CbGeAlD
Levofloxacin—SLC22A4—female reproductive system—ovarian cancer	0.000614	0.0378	CbGeAlD
Levofloxacin—SLC22A4—bone marrow—ovarian cancer	0.00058	0.0357	CbGeAlD
Levofloxacin—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.000568	0.109	CbGdCrCtD
Levofloxacin—SLC22A4—vagina—ovarian cancer	0.000555	0.0342	CbGeAlD
Levofloxacin—TOP2A—lymph node—ovarian cancer	0.000449	0.0277	CbGeAlD
Levofloxacin—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.000391	0.075	CbGdCrCtD
Levofloxacin—SLC22A4—lymph node—ovarian cancer	0.000359	0.0221	CbGeAlD
Levofloxacin—ABCB1—myometrium—ovarian cancer	0.000323	0.0199	CbGeAlD
Levofloxacin—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000314	0.0603	CbGdCrCtD
Levofloxacin—ABCB1—embryo—ovarian cancer	0.000311	0.0192	CbGeAlD
Levofloxacin—CYP3A4—female reproductive system—ovarian cancer	0.000266	0.0164	CbGeAlD
Levofloxacin—ABCB1—epithelium—ovarian cancer	0.000254	0.0156	CbGeAlD
Levofloxacin—ABCB1—uterine cervix—ovarian cancer	0.000252	0.0155	CbGeAlD
Levofloxacin—ABCB1—decidua—ovarian cancer	0.00024	0.0148	CbGeAlD
Levofloxacin—ABCB1—endometrium—ovarian cancer	0.000228	0.014	CbGeAlD
Levofloxacin—ABCB1—gonad—ovarian cancer	0.000211	0.013	CbGeAlD
Levofloxacin—ABCB1—uterus—ovarian cancer	0.00021	0.0129	CbGeAlD
Levofloxacin—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	0.00019	0.0365	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	0.00019	0.0365	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Epirubicin—ovarian cancer	0.00019	0.0365	CbGdCrCtD
Levofloxacin—ABCB1—female reproductive system—ovarian cancer	0.000189	0.0116	CbGeAlD
Levofloxacin—ABCB1—bone marrow—ovarian cancer	0.000178	0.011	CbGeAlD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	0.000176	0.0338	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	0.000176	0.0338	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000176	0.0338	CbGdCrCtD
Levofloxacin—ABCB1—female gonad—ovarian cancer	0.000172	0.0106	CbGeAlD
Levofloxacin—ABCB1—vagina—ovarian cancer	0.000171	0.0105	CbGeAlD
Levofloxacin—ABCB1—testis—ovarian cancer	0.000152	0.00938	CbGeAlD
Levofloxacin—ABCB1—lymph node—ovarian cancer	0.00011	0.0068	CbGeAlD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	9.81e-05	0.0053	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.79e-05	0.00529	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	9.48e-05	0.00512	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RAD51C—ovarian cancer	9.39e-05	0.00508	CbGpPWpGaD
Levofloxacin—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	9.2e-05	0.00497	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	9.18e-05	0.00496	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	8.88e-05	0.0048	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	8.76e-05	0.00474	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ovarian cancer	8.43e-05	0.00456	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—PPP1CC—ovarian cancer	8.21e-05	0.00444	CbGpPWpGaD
Levofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	8.13e-05	0.0044	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	8.03e-05	0.00434	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	7.78e-05	0.00421	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	7.78e-05	0.00421	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	7.75e-05	0.00419	CbGpPWpGaD
Levofloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	7.75e-05	0.00419	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	7.75e-05	0.00419	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.74e-05	0.00418	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	7.64e-05	0.00413	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	7.59e-05	0.0041	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	7.56e-05	0.00409	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RBL2—ovarian cancer	7.54e-05	0.00408	CbGpPWpGaD
Levofloxacin—Photosensitivity reaction—Doxorubicin—ovarian cancer	7.54e-05	0.00031	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Epirubicin—ovarian cancer	7.53e-05	0.00031	CcSEcCtD
Levofloxacin—Anaphylactic shock—Docetaxel—ovarian cancer	7.52e-05	0.00031	CcSEcCtD
Levofloxacin—Oedema—Docetaxel—ovarian cancer	7.52e-05	0.00031	CcSEcCtD
Levofloxacin—Epistaxis—Epirubicin—ovarian cancer	7.51e-05	0.000309	CcSEcCtD
Levofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	7.49e-05	0.00405	CbGpPWpGaD
Levofloxacin—Infection—Docetaxel—ovarian cancer	7.47e-05	0.000308	CcSEcCtD
Levofloxacin—Weight decreased—Doxorubicin—ovarian cancer	7.47e-05	0.000307	CcSEcCtD
Levofloxacin—Sinusitis—Epirubicin—ovarian cancer	7.47e-05	0.000307	CcSEcCtD
Levofloxacin—Hyperglycaemia—Doxorubicin—ovarian cancer	7.45e-05	0.000306	CcSEcCtD
Levofloxacin—Agranulocytosis—Epirubicin—ovarian cancer	7.43e-05	0.000306	CcSEcCtD
Levofloxacin—Pneumonia—Doxorubicin—ovarian cancer	7.41e-05	0.000305	CcSEcCtD
Levofloxacin—Shock—Docetaxel—ovarian cancer	7.4e-05	0.000305	CcSEcCtD
Levofloxacin—Nervous system disorder—Docetaxel—ovarian cancer	7.38e-05	0.000304	CcSEcCtD
Levofloxacin—Thrombocytopenia—Docetaxel—ovarian cancer	7.37e-05	0.000303	CcSEcCtD
Levofloxacin—Drowsiness—Doxorubicin—ovarian cancer	7.36e-05	0.000303	CcSEcCtD
Levofloxacin—Infestation NOS—Doxorubicin—ovarian cancer	7.36e-05	0.000303	CcSEcCtD
Levofloxacin—Infestation—Doxorubicin—ovarian cancer	7.36e-05	0.000303	CcSEcCtD
Levofloxacin—Tachycardia—Docetaxel—ovarian cancer	7.34e-05	0.000302	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	7.33e-05	0.00396	CbGpPWpGaD
Levofloxacin—Feeling abnormal—Paclitaxel—ovarian cancer	7.31e-05	0.000301	CcSEcCtD
Levofloxacin—Skin disorder—Docetaxel—ovarian cancer	7.31e-05	0.000301	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	7.3e-05	0.0003	CcSEcCtD
Levofloxacin—Bradycardia—Epirubicin—ovarian cancer	7.27e-05	0.000299	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.26e-05	0.000299	CcSEcCtD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	7.25e-05	0.00392	CbGpPWpGaD
Levofloxacin—Renal failure—Doxorubicin—ovarian cancer	7.24e-05	0.000298	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.22e-05	0.000297	CcSEcCtD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	7.21e-05	0.0039	CbGpPWpGaD
Levofloxacin—Haemoglobin—Epirubicin—ovarian cancer	7.18e-05	0.000295	CcSEcCtD
Levofloxacin—Jaundice—Doxorubicin—ovarian cancer	7.18e-05	0.000295	CcSEcCtD
Levofloxacin—Stomatitis—Doxorubicin—ovarian cancer	7.18e-05	0.000295	CcSEcCtD
Levofloxacin—Anorexia—Docetaxel—ovarian cancer	7.17e-05	0.000295	CcSEcCtD
Levofloxacin—Rhinitis—Epirubicin—ovarian cancer	7.16e-05	0.000295	CcSEcCtD
Levofloxacin—Conjunctivitis—Doxorubicin—ovarian cancer	7.16e-05	0.000294	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	7.14e-05	0.00386	CbGpPWpGaD
Levofloxacin—Hepatitis—Epirubicin—ovarian cancer	7.14e-05	0.000294	CcSEcCtD
Levofloxacin—Haemorrhage—Epirubicin—ovarian cancer	7.14e-05	0.000294	CcSEcCtD
Levofloxacin—Hypoaesthesia—Epirubicin—ovarian cancer	7.11e-05	0.000292	CcSEcCtD
Levofloxacin—Pharyngitis—Epirubicin—ovarian cancer	7.09e-05	0.000292	CcSEcCtD
Levofloxacin—Urinary tract disorder—Epirubicin—ovarian cancer	7.05e-05	0.00029	CcSEcCtD
Levofloxacin—Urticaria—Paclitaxel—ovarian cancer	7.05e-05	0.00029	CcSEcCtD
Levofloxacin—Oedema peripheral—Epirubicin—ovarian cancer	7.04e-05	0.00029	CcSEcCtD
Levofloxacin—Hypotension—Docetaxel—ovarian cancer	7.03e-05	0.000289	CcSEcCtD
Levofloxacin—Haematuria—Doxorubicin—ovarian cancer	7.02e-05	0.000289	CcSEcCtD
Levofloxacin—Connective tissue disorder—Epirubicin—ovarian cancer	7.02e-05	0.000289	CcSEcCtD
Levofloxacin—Abdominal pain—Paclitaxel—ovarian cancer	7.02e-05	0.000289	CcSEcCtD
Levofloxacin—Body temperature increased—Paclitaxel—ovarian cancer	7.02e-05	0.000289	CcSEcCtD
Levofloxacin—Urethral disorder—Epirubicin—ovarian cancer	7e-05	0.000288	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Doxorubicin—ovarian cancer	6.96e-05	0.000286	CcSEcCtD
Levofloxacin—Epistaxis—Doxorubicin—ovarian cancer	6.94e-05	0.000286	CcSEcCtD
Levofloxacin—Sinusitis—Doxorubicin—ovarian cancer	6.91e-05	0.000284	CcSEcCtD
Levofloxacin—Visual impairment—Epirubicin—ovarian cancer	6.88e-05	0.000283	CcSEcCtD
Levofloxacin—Agranulocytosis—Doxorubicin—ovarian cancer	6.87e-05	0.000283	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	6.85e-05	0.000282	CcSEcCtD
Levofloxacin—Insomnia—Docetaxel—ovarian cancer	6.81e-05	0.00028	CcSEcCtD
Levofloxacin—Paraesthesia—Docetaxel—ovarian cancer	6.76e-05	0.000278	CcSEcCtD
Levofloxacin—Erythema multiforme—Epirubicin—ovarian cancer	6.75e-05	0.000278	CcSEcCtD
Levofloxacin—Bradycardia—Doxorubicin—ovarian cancer	6.73e-05	0.000277	CcSEcCtD
Levofloxacin—Dyspnoea—Docetaxel—ovarian cancer	6.71e-05	0.000276	CcSEcCtD
Levofloxacin—Somnolence—Docetaxel—ovarian cancer	6.69e-05	0.000275	CcSEcCtD
Levofloxacin—Eye disorder—Epirubicin—ovarian cancer	6.68e-05	0.000275	CcSEcCtD
Levofloxacin—Tinnitus—Epirubicin—ovarian cancer	6.66e-05	0.000274	CcSEcCtD
Levofloxacin—Haemoglobin—Doxorubicin—ovarian cancer	6.64e-05	0.000273	CcSEcCtD
Levofloxacin—Cardiac disorder—Epirubicin—ovarian cancer	6.63e-05	0.000273	CcSEcCtD
Levofloxacin—Flushing—Epirubicin—ovarian cancer	6.63e-05	0.000273	CcSEcCtD
Levofloxacin—Rhinitis—Doxorubicin—ovarian cancer	6.63e-05	0.000273	CcSEcCtD
Levofloxacin—Dyspepsia—Docetaxel—ovarian cancer	6.62e-05	0.000272	CcSEcCtD
Levofloxacin—Haemorrhage—Doxorubicin—ovarian cancer	6.61e-05	0.000272	CcSEcCtD
Levofloxacin—Hepatitis—Doxorubicin—ovarian cancer	6.61e-05	0.000272	CcSEcCtD
Levofloxacin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	6.59e-05	0.00356	CbGpPWpGaD
Levofloxacin—Hypoaesthesia—Doxorubicin—ovarian cancer	6.58e-05	0.000271	CcSEcCtD
Levofloxacin—Pharyngitis—Doxorubicin—ovarian cancer	6.56e-05	0.00027	CcSEcCtD
Levofloxacin—Decreased appetite—Docetaxel—ovarian cancer	6.54e-05	0.000269	CcSEcCtD
Levofloxacin—Hypersensitivity—Paclitaxel—ovarian cancer	6.54e-05	0.000269	CcSEcCtD
Levofloxacin—Urinary tract disorder—Doxorubicin—ovarian cancer	6.53e-05	0.000269	CcSEcCtD
Levofloxacin—Oedema peripheral—Doxorubicin—ovarian cancer	6.51e-05	0.000268	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Docetaxel—ovarian cancer	6.5e-05	0.000267	CcSEcCtD
Levofloxacin—Connective tissue disorder—Doxorubicin—ovarian cancer	6.49e-05	0.000267	CcSEcCtD
Levofloxacin—Fatigue—Docetaxel—ovarian cancer	6.49e-05	0.000267	CcSEcCtD
Levofloxacin—Angiopathy—Epirubicin—ovarian cancer	6.48e-05	0.000267	CcSEcCtD
Levofloxacin—Urethral disorder—Doxorubicin—ovarian cancer	6.48e-05	0.000267	CcSEcCtD
Levofloxacin—Immune system disorder—Epirubicin—ovarian cancer	6.45e-05	0.000265	CcSEcCtD
Levofloxacin—Mediastinal disorder—Epirubicin—ovarian cancer	6.44e-05	0.000265	CcSEcCtD
Levofloxacin—Pain—Docetaxel—ovarian cancer	6.43e-05	0.000265	CcSEcCtD
Levofloxacin—Constipation—Docetaxel—ovarian cancer	6.43e-05	0.000265	CcSEcCtD
Levofloxacin—Chills—Epirubicin—ovarian cancer	6.41e-05	0.000264	CcSEcCtD
Levofloxacin—Arrhythmia—Epirubicin—ovarian cancer	6.38e-05	0.000263	CcSEcCtD
Levofloxacin—Visual impairment—Doxorubicin—ovarian cancer	6.37e-05	0.000262	CcSEcCtD
Levofloxacin—Asthenia—Paclitaxel—ovarian cancer	6.37e-05	0.000262	CcSEcCtD
Levofloxacin—Alopecia—Epirubicin—ovarian cancer	6.31e-05	0.00026	CcSEcCtD
Levofloxacin—Pruritus—Paclitaxel—ovarian cancer	6.28e-05	0.000258	CcSEcCtD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	6.28e-05	0.00339	CbGpPWpGaD
Levofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	6.27e-05	0.00339	CbGpPWpGaD
Levofloxacin—Mental disorder—Epirubicin—ovarian cancer	6.26e-05	0.000257	CcSEcCtD
Levofloxacin—Erythema multiforme—Doxorubicin—ovarian cancer	6.25e-05	0.000257	CcSEcCtD
Levofloxacin—Erythema—Epirubicin—ovarian cancer	6.22e-05	0.000256	CcSEcCtD
Levofloxacin—Malnutrition—Epirubicin—ovarian cancer	6.22e-05	0.000256	CcSEcCtD
Levofloxacin—Feeling abnormal—Docetaxel—ovarian cancer	6.2e-05	0.000255	CcSEcCtD
Levofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	6.19e-05	0.00335	CbGpPWpGaD
Levofloxacin—Eye disorder—Doxorubicin—ovarian cancer	6.18e-05	0.000254	CcSEcCtD
Levofloxacin—Tinnitus—Doxorubicin—ovarian cancer	6.16e-05	0.000254	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Docetaxel—ovarian cancer	6.15e-05	0.000253	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—ovarian cancer	6.13e-05	0.000252	CcSEcCtD
Levofloxacin—Cardiac disorder—Doxorubicin—ovarian cancer	6.13e-05	0.000252	CcSEcCtD
Levofloxacin—Flatulence—Epirubicin—ovarian cancer	6.13e-05	0.000252	CcSEcCtD
Levofloxacin—Tension—Epirubicin—ovarian cancer	6.1e-05	0.000251	CcSEcCtD
Levofloxacin—Dysgeusia—Epirubicin—ovarian cancer	6.09e-05	0.000251	CcSEcCtD
Levofloxacin—Diarrhoea—Paclitaxel—ovarian cancer	6.07e-05	0.00025	CcSEcCtD
Levofloxacin—Nervousness—Epirubicin—ovarian cancer	6.04e-05	0.000248	CcSEcCtD
Levofloxacin—Back pain—Epirubicin—ovarian cancer	6.01e-05	0.000247	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—ovarian cancer	6e-05	0.000247	CcSEcCtD
Levofloxacin—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	5.98e-05	0.00324	CbGpPWpGaD
Levofloxacin—Muscle spasms—Epirubicin—ovarian cancer	5.98e-05	0.000246	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—ovarian cancer	5.97e-05	0.000246	CcSEcCtD
Levofloxacin—Mediastinal disorder—Doxorubicin—ovarian cancer	5.96e-05	0.000245	CcSEcCtD
Levofloxacin—Abdominal pain—Docetaxel—ovarian cancer	5.95e-05	0.000245	CcSEcCtD
Levofloxacin—Body temperature increased—Docetaxel—ovarian cancer	5.95e-05	0.000245	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	5.93e-05	0.00321	CbGpPWpGaD
Levofloxacin—Chills—Doxorubicin—ovarian cancer	5.93e-05	0.000244	CcSEcCtD
Levofloxacin—Arrhythmia—Doxorubicin—ovarian cancer	5.9e-05	0.000243	CcSEcCtD
Levofloxacin—Dizziness—Paclitaxel—ovarian cancer	5.87e-05	0.000242	CcSEcCtD
Levofloxacin—Vision blurred—Epirubicin—ovarian cancer	5.86e-05	0.000241	CcSEcCtD
Levofloxacin—Alopecia—Doxorubicin—ovarian cancer	5.84e-05	0.00024	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.79e-05	0.00313	CbGpPWpGaD
Levofloxacin—Mental disorder—Doxorubicin—ovarian cancer	5.79e-05	0.000238	CcSEcCtD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	5.79e-05	0.00313	CbGpPWpGaD
Levofloxacin—Ill-defined disorder—Epirubicin—ovarian cancer	5.77e-05	0.000237	CcSEcCtD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	5.76e-05	0.00312	CbGpPWpGaD
Levofloxacin—Erythema—Doxorubicin—ovarian cancer	5.75e-05	0.000237	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—ovarian cancer	5.75e-05	0.000237	CcSEcCtD
Levofloxacin—Anaemia—Epirubicin—ovarian cancer	5.75e-05	0.000236	CcSEcCtD
Levofloxacin—Agitation—Epirubicin—ovarian cancer	5.71e-05	0.000235	CcSEcCtD
Levofloxacin—Flatulence—Doxorubicin—ovarian cancer	5.67e-05	0.000233	CcSEcCtD
Levofloxacin—Tension—Doxorubicin—ovarian cancer	5.65e-05	0.000232	CcSEcCtD
Levofloxacin—Vomiting—Paclitaxel—ovarian cancer	5.64e-05	0.000232	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—ovarian cancer	5.63e-05	0.000232	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	5.61e-05	0.00303	CbGpPWpGaD
Levofloxacin—Malaise—Epirubicin—ovarian cancer	5.61e-05	0.000231	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	5.61e-05	0.00303	CbGpPWpGaD
Levofloxacin—Rash—Paclitaxel—ovarian cancer	5.6e-05	0.00023	CcSEcCtD
Levofloxacin—Dermatitis—Paclitaxel—ovarian cancer	5.59e-05	0.00023	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—ovarian cancer	5.59e-05	0.00023	CcSEcCtD
Levofloxacin—Vertigo—Epirubicin—ovarian cancer	5.59e-05	0.00023	CcSEcCtD
Levofloxacin—Syncope—Epirubicin—ovarian cancer	5.58e-05	0.000229	CcSEcCtD
Levofloxacin—Leukopenia—Epirubicin—ovarian cancer	5.57e-05	0.000229	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—ovarian cancer	5.57e-05	0.000229	CcSEcCtD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	5.56e-05	0.00301	CbGpPWpGaD
Levofloxacin—Headache—Paclitaxel—ovarian cancer	5.56e-05	0.000229	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.55e-05	0.003	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Docetaxel—ovarian cancer	5.54e-05	0.000228	CcSEcCtD
Levofloxacin—Muscle spasms—Doxorubicin—ovarian cancer	5.53e-05	0.000228	CcSEcCtD
Levofloxacin—Palpitations—Epirubicin—ovarian cancer	5.5e-05	0.000226	CcSEcCtD
Levofloxacin—Loss of consciousness—Epirubicin—ovarian cancer	5.47e-05	0.000225	CcSEcCtD
Levofloxacin—Cough—Epirubicin—ovarian cancer	5.43e-05	0.000223	CcSEcCtD
Levofloxacin—Vision blurred—Doxorubicin—ovarian cancer	5.42e-05	0.000223	CcSEcCtD
Levofloxacin—Asthenia—Docetaxel—ovarian cancer	5.4e-05	0.000222	CcSEcCtD
Levofloxacin—Hypertension—Epirubicin—ovarian cancer	5.37e-05	0.000221	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—ovarian cancer	5.34e-05	0.00022	CcSEcCtD
Levofloxacin—Pruritus—Docetaxel—ovarian cancer	5.32e-05	0.000219	CcSEcCtD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	5.32e-05	0.00288	CbGpPWpGaD
Levofloxacin—Anaemia—Doxorubicin—ovarian cancer	5.32e-05	0.000219	CcSEcCtD
Levofloxacin—Chest pain—Epirubicin—ovarian cancer	5.29e-05	0.000218	CcSEcCtD
Levofloxacin—Arthralgia—Epirubicin—ovarian cancer	5.29e-05	0.000218	CcSEcCtD
Levofloxacin—Myalgia—Epirubicin—ovarian cancer	5.29e-05	0.000218	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—ovarian cancer	5.29e-05	0.000218	CcSEcCtD
Levofloxacin—Anxiety—Epirubicin—ovarian cancer	5.28e-05	0.000217	CcSEcCtD
Levofloxacin—Nausea—Paclitaxel—ovarian cancer	5.27e-05	0.000217	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	5.26e-05	0.000216	CcSEcCtD
Levofloxacin—Discomfort—Epirubicin—ovarian cancer	5.23e-05	0.000215	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—ovarian cancer	5.19e-05	0.000213	CcSEcCtD
Levofloxacin—Dry mouth—Epirubicin—ovarian cancer	5.18e-05	0.000213	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—ovarian cancer	5.17e-05	0.000213	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.16e-05	0.00279	CbGpPWpGaD
Levofloxacin—Syncope—Doxorubicin—ovarian cancer	5.16e-05	0.000212	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—ovarian cancer	5.15e-05	0.000212	CcSEcCtD
Levofloxacin—Diarrhoea—Docetaxel—ovarian cancer	5.15e-05	0.000212	CcSEcCtD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	5.13e-05	0.00277	CbGpPWpGaD
Levofloxacin—Confusional state—Epirubicin—ovarian cancer	5.12e-05	0.000211	CcSEcCtD
Levofloxacin—Palpitations—Doxorubicin—ovarian cancer	5.08e-05	0.000209	CcSEcCtD
Levofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.08e-05	0.00275	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	5.08e-05	0.00274	CbGpPWpGaD
Levofloxacin—Oedema—Epirubicin—ovarian cancer	5.07e-05	0.000209	CcSEcCtD
Levofloxacin—Anaphylactic shock—Epirubicin—ovarian cancer	5.07e-05	0.000209	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—MLH1—ovarian cancer	5.07e-05	0.00274	CbGpPWpGaD
Levofloxacin—Loss of consciousness—Doxorubicin—ovarian cancer	5.06e-05	0.000208	CcSEcCtD
Levofloxacin—Infection—Epirubicin—ovarian cancer	5.04e-05	0.000207	CcSEcCtD
Levofloxacin—Cough—Doxorubicin—ovarian cancer	5.02e-05	0.000207	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—SKP2—ovarian cancer	5.02e-05	0.00271	CbGpPWpGaD
Levofloxacin—Shock—Epirubicin—ovarian cancer	4.99e-05	0.000205	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.98e-05	0.0027	CbGpPWpGaD
Levofloxacin—Nervous system disorder—Epirubicin—ovarian cancer	4.98e-05	0.000205	CcSEcCtD
Levofloxacin—Dizziness—Docetaxel—ovarian cancer	4.98e-05	0.000205	CcSEcCtD
Levofloxacin—Thrombocytopenia—Epirubicin—ovarian cancer	4.97e-05	0.000204	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—ovarian cancer	4.97e-05	0.000204	CcSEcCtD
Levofloxacin—Tachycardia—Epirubicin—ovarian cancer	4.95e-05	0.000204	CcSEcCtD
Levofloxacin—Skin disorder—Epirubicin—ovarian cancer	4.93e-05	0.000203	CcSEcCtD
Levofloxacin—Hyperhidrosis—Epirubicin—ovarian cancer	4.91e-05	0.000202	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—ovarian cancer	4.9e-05	0.000202	CcSEcCtD
Levofloxacin—Myalgia—Doxorubicin—ovarian cancer	4.9e-05	0.000202	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—ovarian cancer	4.9e-05	0.000202	CcSEcCtD
Levofloxacin—Anxiety—Doxorubicin—ovarian cancer	4.88e-05	0.000201	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	4.87e-05	0.00263	CbGpPWpGaD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	4.86e-05	0.0002	CcSEcCtD
Levofloxacin—Discomfort—Doxorubicin—ovarian cancer	4.84e-05	0.000199	CcSEcCtD
Levofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	4.84e-05	0.00262	CbGpPWpGaD
Levofloxacin—Anorexia—Epirubicin—ovarian cancer	4.84e-05	0.000199	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.83e-05	0.00261	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	4.8e-05	0.0026	CbGpPWpGaD
Levofloxacin—Dry mouth—Doxorubicin—ovarian cancer	4.79e-05	0.000197	CcSEcCtD
Levofloxacin—Vomiting—Docetaxel—ovarian cancer	4.78e-05	0.000197	CcSEcCtD
Levofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	4.77e-05	0.00258	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	4.75e-05	0.00257	CbGpPWpGaD
Levofloxacin—Rash—Docetaxel—ovarian cancer	4.74e-05	0.000195	CcSEcCtD
Levofloxacin—Hypotension—Epirubicin—ovarian cancer	4.74e-05	0.000195	CcSEcCtD
Levofloxacin—Dermatitis—Docetaxel—ovarian cancer	4.74e-05	0.000195	CcSEcCtD
Levofloxacin—Confusional state—Doxorubicin—ovarian cancer	4.73e-05	0.000195	CcSEcCtD
Levofloxacin—Headache—Docetaxel—ovarian cancer	4.71e-05	0.000194	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—ovarian cancer	4.7e-05	0.000193	CcSEcCtD
Levofloxacin—Anaphylactic shock—Doxorubicin—ovarian cancer	4.7e-05	0.000193	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—ovarian cancer	4.66e-05	0.000192	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	4.64e-05	0.00251	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.63e-05	0.0025	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.62e-05	0.00019	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—ovarian cancer	4.62e-05	0.00019	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—ovarian cancer	4.6e-05	0.000189	CcSEcCtD
Levofloxacin—Thrombocytopenia—Doxorubicin—ovarian cancer	4.6e-05	0.000189	CcSEcCtD
Levofloxacin—Insomnia—Epirubicin—ovarian cancer	4.59e-05	0.000189	CcSEcCtD
Levofloxacin—Tachycardia—Doxorubicin—ovarian cancer	4.58e-05	0.000189	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—ovarian cancer	4.56e-05	0.000188	CcSEcCtD
Levofloxacin—Paraesthesia—Epirubicin—ovarian cancer	4.56e-05	0.000187	CcSEcCtD
Levofloxacin—Hyperhidrosis—Doxorubicin—ovarian cancer	4.54e-05	0.000187	CcSEcCtD
Levofloxacin—Dyspnoea—Epirubicin—ovarian cancer	4.52e-05	0.000186	CcSEcCtD
Levofloxacin—Somnolence—Epirubicin—ovarian cancer	4.51e-05	0.000186	CcSEcCtD
Levofloxacin—Anorexia—Doxorubicin—ovarian cancer	4.48e-05	0.000184	CcSEcCtD
Levofloxacin—Nausea—Docetaxel—ovarian cancer	4.47e-05	0.000184	CcSEcCtD
Levofloxacin—Dyspepsia—Epirubicin—ovarian cancer	4.47e-05	0.000184	CcSEcCtD
Levofloxacin—Decreased appetite—Epirubicin—ovarian cancer	4.41e-05	0.000181	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.39e-05	0.00237	CbGpPWpGaD
Levofloxacin—Hypotension—Doxorubicin—ovarian cancer	4.39e-05	0.000181	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.38e-05	0.00018	CcSEcCtD
Levofloxacin—Fatigue—Epirubicin—ovarian cancer	4.38e-05	0.00018	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	4.35e-05	0.00235	CbGpPWpGaD
Levofloxacin—Pain—Epirubicin—ovarian cancer	4.34e-05	0.000179	CcSEcCtD
Levofloxacin—Constipation—Epirubicin—ovarian cancer	4.34e-05	0.000179	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	4.3e-05	0.00232	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.28e-05	0.000176	CcSEcCtD
Levofloxacin—Insomnia—Doxorubicin—ovarian cancer	4.25e-05	0.000175	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—ovarian cancer	4.22e-05	0.000173	CcSEcCtD
Levofloxacin—Dyspnoea—Doxorubicin—ovarian cancer	4.19e-05	0.000172	CcSEcCtD
Levofloxacin—Feeling abnormal—Epirubicin—ovarian cancer	4.18e-05	0.000172	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—ovarian cancer	4.17e-05	0.000172	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Epirubicin—ovarian cancer	4.15e-05	0.000171	CcSEcCtD
Levofloxacin—Dyspepsia—Doxorubicin—ovarian cancer	4.13e-05	0.00017	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—CHEK2—ovarian cancer	4.1e-05	0.00222	CbGpPWpGaD
Levofloxacin—Decreased appetite—Doxorubicin—ovarian cancer	4.08e-05	0.000168	CcSEcCtD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	4.07e-05	0.0022	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	4.05e-05	0.00219	CbGpPWpGaD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.05e-05	0.000167	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—ovarian cancer	4.05e-05	0.000167	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	4.03e-05	0.00218	CbGpPWpGaD
Levofloxacin—Urticaria—Epirubicin—ovarian cancer	4.03e-05	0.000166	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—ovarian cancer	4.02e-05	0.000165	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—ovarian cancer	4.02e-05	0.000165	CcSEcCtD
Levofloxacin—Body temperature increased—Epirubicin—ovarian cancer	4.01e-05	0.000165	CcSEcCtD
Levofloxacin—Abdominal pain—Epirubicin—ovarian cancer	4.01e-05	0.000165	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	3.95e-05	0.00214	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	3.94e-05	0.00213	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.94e-05	0.00213	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	3.92e-05	0.00212	CbGpPWpGaD
Levofloxacin—Feeling abnormal—Doxorubicin—ovarian cancer	3.87e-05	0.000159	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	3.85e-05	0.00208	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCND2—ovarian cancer	3.84e-05	0.00208	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—BRCA1—ovarian cancer	3.84e-05	0.00208	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.84e-05	0.000158	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	3.81e-05	0.00206	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NME2—ovarian cancer	3.77e-05	0.00204	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	3.77e-05	0.00204	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Epirubicin—ovarian cancer	3.74e-05	0.000154	CcSEcCtD
Levofloxacin—Urticaria—Doxorubicin—ovarian cancer	3.73e-05	0.000153	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	3.71e-05	0.00201	CbGpPWpGaD
Levofloxacin—Body temperature increased—Doxorubicin—ovarian cancer	3.71e-05	0.000153	CcSEcCtD
Levofloxacin—Abdominal pain—Doxorubicin—ovarian cancer	3.71e-05	0.000153	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	3.7e-05	0.002	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.66e-05	0.00198	CbGpPWpGaD
Levofloxacin—Asthenia—Epirubicin—ovarian cancer	3.64e-05	0.00015	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	3.63e-05	0.00196	CbGpPWpGaD
Levofloxacin—Pruritus—Epirubicin—ovarian cancer	3.59e-05	0.000148	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	3.56e-05	0.00193	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—BRCA2—ovarian cancer	3.48e-05	0.00188	CbGpPWpGaD
Levofloxacin—Diarrhoea—Epirubicin—ovarian cancer	3.47e-05	0.000143	CcSEcCtD
Levofloxacin—Hypersensitivity—Doxorubicin—ovarian cancer	3.46e-05	0.000142	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	3.41e-05	0.00185	CbGpPWpGaD
Levofloxacin—Asthenia—Doxorubicin—ovarian cancer	3.37e-05	0.000139	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—CCNE1—ovarian cancer	3.37e-05	0.00182	CbGpPWpGaD
Levofloxacin—Dizziness—Epirubicin—ovarian cancer	3.36e-05	0.000138	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.35e-05	0.00181	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	3.33e-05	0.0018	CbGpPWpGaD
Levofloxacin—Pruritus—Doxorubicin—ovarian cancer	3.32e-05	0.000137	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	3.31e-05	0.00179	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	3.31e-05	0.00179	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TYMS—ovarian cancer	3.31e-05	0.00179	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	3.24e-05	0.00175	CbGpPWpGaD
Levofloxacin—Vomiting—Epirubicin—ovarian cancer	3.23e-05	0.000133	CcSEcCtD
Levofloxacin—Diarrhoea—Doxorubicin—ovarian cancer	3.21e-05	0.000132	CcSEcCtD
Levofloxacin—Rash—Epirubicin—ovarian cancer	3.2e-05	0.000132	CcSEcCtD
Levofloxacin—Dermatitis—Epirubicin—ovarian cancer	3.2e-05	0.000132	CcSEcCtD
Levofloxacin—Headache—Epirubicin—ovarian cancer	3.18e-05	0.000131	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	3.17e-05	0.00171	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	3.12e-05	0.00169	CbGpPWpGaD
Levofloxacin—Dizziness—Doxorubicin—ovarian cancer	3.11e-05	0.000128	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	3.08e-05	0.00167	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	3.02e-05	0.00163	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	3.02e-05	0.00163	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	3.02e-05	0.00163	CbGpPWpGaD
Levofloxacin—Nausea—Epirubicin—ovarian cancer	3.01e-05	0.000124	CcSEcCtD
Levofloxacin—Vomiting—Doxorubicin—ovarian cancer	2.99e-05	0.000123	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—BIRC5—ovarian cancer	2.97e-05	0.00161	CbGpPWpGaD
Levofloxacin—Rash—Doxorubicin—ovarian cancer	2.96e-05	0.000122	CcSEcCtD
Levofloxacin—Dermatitis—Doxorubicin—ovarian cancer	2.96e-05	0.000122	CcSEcCtD
Levofloxacin—Headache—Doxorubicin—ovarian cancer	2.94e-05	0.000121	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.93e-05	0.00158	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	2.92e-05	0.00158	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TERT—ovarian cancer	2.88e-05	0.00156	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.85e-05	0.00154	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.83e-05	0.00153	CbGpPWpGaD
Levofloxacin—Nausea—Doxorubicin—ovarian cancer	2.79e-05	0.000115	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	2.75e-05	0.00149	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	2.75e-05	0.00149	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	2.72e-05	0.00147	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	2.7e-05	0.00146	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	2.66e-05	0.00144	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	2.64e-05	0.00143	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.64e-05	0.00143	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—CASP3—ovarian cancer	2.64e-05	0.00143	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL2—ovarian cancer	2.63e-05	0.00142	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.62e-05	0.00142	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	2.58e-05	0.0014	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.56e-05	0.00138	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.53e-05	0.00137	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.53e-05	0.00137	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.53e-05	0.00137	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.52e-05	0.00136	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.48e-05	0.00134	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.48e-05	0.00134	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.48e-05	0.00134	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.44e-05	0.00132	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYTB—ovarian cancer	2.43e-05	0.00132	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	2.43e-05	0.00132	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.36e-05	0.00127	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	2.34e-05	0.00127	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.24e-05	0.00121	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.23e-05	0.00121	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	2.23e-05	0.0012	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.14e-05	0.00116	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—BRIP1—ovarian cancer	2.13e-05	0.00115	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PPP1CC—ovarian cancer	2.13e-05	0.00115	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.08e-05	0.00113	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.08e-05	0.00113	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NME2—ovarian cancer	2.06e-05	0.00111	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.05e-05	0.00111	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2e-05	0.00108	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	1.99e-05	0.00108	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	1.95e-05	0.00106	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.95e-05	0.00106	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	1.86e-05	0.00101	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.86e-05	0.00101	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.85e-05	0.000998	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.75e-05	0.000948	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	1.75e-05	0.000944	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCND1—ovarian cancer	1.66e-05	0.0009	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.65e-05	0.000891	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NME2—ovarian cancer	1.65e-05	0.00089	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.54e-05	0.00083	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	1.49e-05	0.000807	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.46e-05	0.00079	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.43e-05	0.000775	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—YAP1—ovarian cancer	1.43e-05	0.000771	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.41e-05	0.000761	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.4e-05	0.000755	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MAPK3—ovarian cancer	1.37e-05	0.000742	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—MAPK1—ovarian cancer	1.34e-05	0.000726	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYC—ovarian cancer	1.34e-05	0.000722	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.33e-05	0.000721	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYTB—ovarian cancer	1.33e-05	0.000718	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.33e-05	0.000718	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MAPK1—ovarian cancer	1.31e-05	0.000706	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.3e-05	0.000703	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.29e-05	0.000696	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NME2—ovarian cancer	1.27e-05	0.000687	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.27e-05	0.000685	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.25e-05	0.000678	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.22e-05	0.000661	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—FASN—ovarian cancer	1.16e-05	0.000628	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—BRIP1—ovarian cancer	1.16e-05	0.000628	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.16e-05	0.000628	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC5A5—ovarian cancer	1.14e-05	0.000618	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.14e-05	0.000615	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC2A1—ovarian cancer	1.1e-05	0.000597	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.1e-05	0.000597	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—ovarian cancer	1.1e-05	0.000593	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—HRAS—ovarian cancer	1.08e-05	0.000583	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYTB—ovarian cancer	1.06e-05	0.000574	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP1B1—ovarian cancer	1.06e-05	0.000572	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.04e-05	0.000565	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.04e-05	0.000561	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.02e-05	0.000549	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	9.94e-06	0.000537	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	9.94e-06	0.000537	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	9.39e-06	0.000508	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.39e-06	0.000507	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PPP1CC—ovarian cancer	9.27e-06	0.000501	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—BRIP1—ovarian cancer	9.27e-06	0.000501	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCB1—ovarian cancer	8.72e-06	0.000471	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.62e-06	0.000466	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TYMS—ovarian cancer	8.56e-06	0.000463	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.34e-06	0.000451	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYTB—ovarian cancer	8.19e-06	0.000443	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—YAP1—ovarian cancer	7.79e-06	0.000421	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.16e-06	0.000387	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.16e-06	0.000387	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.04e-06	0.000381	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CAV1—ovarian cancer	6.9e-06	0.000373	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.76e-06	0.000365	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—FASN—ovarian cancer	6.35e-06	0.000343	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CG—ovarian cancer	6.28e-06	0.00034	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.25e-06	0.000338	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—YAP1—ovarian cancer	6.22e-06	0.000336	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.15e-06	0.000333	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.03e-06	0.000326	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.78e-06	0.000313	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CD—ovarian cancer	5.52e-06	0.000299	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.41e-06	0.000293	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.13e-06	0.000277	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—FASN—ovarian cancer	5.07e-06	0.000274	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.99e-06	0.00027	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.82e-06	0.00026	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CB—ovarian cancer	4.82e-06	0.00026	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—YAP1—ovarian cancer	4.8e-06	0.000259	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.72e-06	0.000255	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TYMS—ovarian cancer	4.68e-06	0.000253	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP1B1—ovarian cancer	4.62e-06	0.00025	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTEN—ovarian cancer	4.16e-06	0.000225	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.09e-06	0.000221	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.07e-06	0.00022	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—FASN—ovarian cancer	3.91e-06	0.000212	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.85e-06	0.000208	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.8e-06	0.000206	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CAV1—ovarian cancer	3.77e-06	0.000204	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TYMS—ovarian cancer	3.73e-06	0.000202	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.72e-06	0.000201	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.56e-06	0.000193	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.43e-06	0.000186	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.16e-06	0.000171	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.02e-06	0.000163	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CAV1—ovarian cancer	3.01e-06	0.000163	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CA—ovarian cancer	2.94e-06	0.000159	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.93e-06	0.000159	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TYMS—ovarian cancer	2.88e-06	0.000156	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.87e-06	0.000155	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.74e-06	0.000148	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.63e-06	0.000142	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.41e-06	0.00013	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AKT1—ovarian cancer	2.4e-06	0.00013	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CAV1—ovarian cancer	2.32e-06	0.000126	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTEN—ovarian cancer	2.27e-06	0.000123	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.12e-06	0.000114	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.1e-06	0.000114	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.86e-06	0.000101	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTEN—ovarian cancer	1.81e-06	9.81e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.62e-06	8.76e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.6e-06	8.67e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTEN—ovarian cancer	1.4e-06	7.57e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AKT1—ovarian cancer	1.31e-06	7.08e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.28e-06	6.92e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AKT1—ovarian cancer	1.05e-06	5.65e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	9.88e-07	5.34e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AKT1—ovarian cancer	8.07e-07	4.36e-05	CbGpPWpGaD
Levofloxacin—Sparfloxacin—ABCB1—ovarian cancer	3.55e-07	0.595	CrCbGaD
Levofloxacin—Ciprofloxacin—ABCB1—ovarian cancer	2.41e-07	0.405	CrCbGaD
